Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Interest Coverage Ratio for 5 consecutive years, with 0.98 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio rose 77.55% year-over-year to 0.98; the TTM value through Mar 2026 reached 1.47, up 62.65%, while the annual FY2025 figure was 2.35, 39.04% up from the prior year.
  • Interest Coverage Ratio hit 0.98 in Q1 2026 for Phathom Pharmaceuticals, down from 0.36 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.36 in Q4 2025 and bottomed at 13.74 in Q1 2022.
  • Average Interest Coverage Ratio over 5 years is 4.24, with a median of 3.83 recorded in 2024.
  • Year-over-year, Interest Coverage Ratio tumbled 31.98% in 2024 and then surged 88.7% in 2025.
  • Phathom Pharmaceuticals' Interest Coverage Ratio stood at 4.86 in 2022, then decreased by 10.41% to 5.36 in 2023, then skyrocketed by 40.41% to 3.2 in 2024, then soared by 88.7% to 0.36 in 2025, then plummeted by 171.36% to 0.98 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 0.98, 0.36, and 0.95 for Q1 2026, Q4 2025, and Q3 2025 respectively.